Abstracts tagged "Work Disability"

Abstract Number: 105 • 2014 ACR/ARHP Annual Meeting
Resource Use and Health Related Quality of Life Burden of Gout Exacerbated By Common Comorbidities: Results from the 2012-2013 National Health and Wellness Survey
Robert Morlock¹, Natalia M. Flores², Kathy Annunziata³, J. Chapnick⁴ and Sulabha Ramachandran⁵, ¹4939 Directors Place, Ardea Biosciences, San Diego, CA, ²Kantar Health, Foster City, CA, ³Kantar Health, Princeton, NJ, ⁴Kantar Health, Horsham, PA, ⁵AstraZeneca, Wilmington, DE
Background/Purpose: Gout is caused by chronic high serum uric acid (SUA) levels (i.e., hyperuricemia), which leads to the deposition of monosodium urate crystals in musculoskeletal…
Abstract Number: 904 • 2013 ACR/ARHP Annual Meeting
Worse Mental Health In Employed Adult Patients With Juvenile Idiopathic Arthritis (JIA): More Than Just A Job
Nadia E. Aikawa¹, Jms Gordo², R Krieger³, LE Paula⁴ and Claudia Goldenstein-Schainberg¹, ¹Reumatologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, ²Reumatologia, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil, ³Reumatologia, Universidade de Sao Paulo, Sao Paulo, Brazil, ⁴Reumatologia, Faculdade de Medicina, Universidade de São Paulo, Sao PAulo, Brazil
Background/Purpose: Work status and unemployment are significant future concerns among individuals with JIA, because roughly 20% patients enter adulthood with clinically active disease and disabled.…
Abstract Number: 337 • 2013 ACR/ARHP Annual Meeting
Fatigue and Work Disability In Psoriatic Arthritis
Jessica Walsh¹, Molly McFadden², Gerald G. Krueger³, Allen D. Sawitzke¹ and Daniel O. Clegg⁴, ¹Rheumatology, University of Utah, Salt Lake City, UT, ²Internal Medicine-Division of Epidemiology, University of Utah, SLC, UT, ³Dermatology, University of Utah, Salt Lake City, UT, ⁴Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT
Background/Purpose: Fatigue and work disability (WD) are common in people with psoriatic arthritis (PsA). Pain and discomfort from PsA contribute to fatigue by impairing sleep…
Abstract Number: 2451 • 2013 ACR/ARHP Annual Meeting
Work Instability Scores In Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Are Equal and Higher Than In Psoriatic Arthritis
Sherry Rohekar¹, Robert D. Inman² and Dafna D. Gladman³, ¹Rheumatology, St. Joseph's Hospital, London, ON, Canada, ²Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Clinical subsets of spondyloarthitis (SpA), such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA) may be associated with significant impact on work performance and…
Abstract Number: 1081 • 2013 ACR/ARHP Annual Meeting
The Effects of Coexisting Cervical Myofascial Pain Syndromes On Pain and Disability of the Computer Users With Cumulative Trauma Disorders
Hakan Genc¹, Ozgul Bozkurt Tuncer², Hatice Rana Erdem³, Baris Nacir¹, Aynur Karagoz¹ and Burcu Duyur Cakit¹, ¹Department of Physical Medicine and Rehabilitation, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey, ²Department of Physical Medicine and Rehabilitation, Ministry of Health, Yuksekova Public Hospital, Hakkari, Turkey, ³Department of Physical Medicine and Rehabilitation, Ahi Evran University, Kirsehir, Turkey
Background/Purpose: Coexisting cervical myofascial pain syndromes (MPS) can have serious effects on pain and disability of computer users with cumulative trauma disorders (CTD). The aims of…
Abstract Number: 1011 • 2013 ACR/ARHP Annual Meeting
Psychiatric and Cardiovascular Comorbidities As Causes Of Work Disability Among Individuals With Rheumatoid Arthritis
Anne M. Kerola¹, Tuomo Nieminen², Markku J. Kauppi³, Hannu Kautiainen⁴, Tuomas Kerola³, Lauri J. Virta⁵, Timo Pohjolainen⁶ and Kari Puolakka⁷, ¹Medical School, University of Helsinki, Helsinki, Finland, ²Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland, ³Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, ⁴Unit of Primary Health Care, Helsinki University Central Hospital, Helsinki, Finland, ⁵Research Department, the Social Insurance Institution, Turku, Finland, ⁶ORTON Rehabilitation Centre, ORTON Foundation, Helsinki, Finland, ⁷Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland
Background/Purpose: A remarkable proportion of rheumatoid arthritis (RA) patients stop working before the normal age of retirement. Initial research data suggests that comorbidities, with depression…
Abstract Number: 1372 • 2012 ACR/ARHP Annual Meeting
Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
Désirée van der Heijde¹, Jürgen Braun², Martin Rudwaleit³, Oana Purcaru⁴ and Arthur Kavanaugh⁵, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³Endokrinologikum Berlin, Berlin, Germany, ⁴UCB Pharma, Braine, Belgium, ⁵UCSD School of Medicine, La Jolla, CA
Background/Purpose: Axial spondyloarthritis (axSpA) includes both ankylosing spondylitis (AS) and non-radiographic axial SpA (nr-axSpA). AS significantly affects patients' (pts) work productivity.1 The impact of the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].